Monitoring Patients on IBD Therapies: How to Monitor? What Is the Im…

Cedars Sinai

C. Ha

Use of Concomitant Medications in IBD-Evidence, Outcomes, and Risks

Boston University Chobanian & Avedisian School of Medicine

M. Kappelman

Guidelines for Ulcerative Colitis Diagnosis and Management

UChicago Medicine

D. T. Rubin

Positioning Therapies in IBD (audio only)

Asher Kornbluth

Positioning Medical Therapy in IBD

Washington University in St. Louis

M. Ciorba

Role of Inflammation in Cardiovascular Disease

San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

M. Rosa Costanzo

The Microbiome in Pain, Inflammation & Toxin Overload

Scripps Health

R. Bonakdar

Advanced UC Drugs & Positioning - November 2023, IBD School (Sydney,…

Rubin Lab

D. T. Rubin

EADV 2023 Insights: Non-Melanoma Skin Cancer Management in Organ Tra…

EADV 2023 Insights

G. Hofbauer

Optimizing Current IBD Therapies

University of Colorado Department of Medicine

M. Long

What’s New with the Old: Anti-TNFs and Anti-Integrins in IBD

Scripps Health

J. Sauk

Panel: Positioning of Therapies in IBD in 2024

Boston University Chobanian & Avedisian School of Medicine

L. Grossberg, M. Kappelman, G. Lichtenstein, M. Hamilton

Goals of Treatment in IBD: Treatment Endpoints and Putting Risks int…

MedStar Georgetown and Northwestern University IBD Masterclass

C. Siegel

Management of Pouchitis and Its Complications

MetroHealth

B. Shen

Positioning Therapies for Ulcerative Colitis: The Art (and Science) …

Scripps Health

S. Singh

IL12/23 and IL23 Selective Inhibition in Inflammatory Bowel Disease

Gil Melmed

New and Emerging Treatments for IBD in 2024

University of Colorado Department of Medicine

M. Chiorean

State of the Art Management of IBD: How Should We Sequence Therapies…

Rubin Lab

D. T. Rubin

New and Emerging Therapies for Inflammatory Bowel Disease

University of Colorado Department of Medicine

W. Ahmed

How I Optimize Biologic Therapies in IBD

Providence Swedish

T. L. Zisman